Concepedia

Boh-Ram Kim

BK

Statistics

Publications

2

Citations

81

H-Index

2

Active since

2013

Affiliations

National Cancer Center(Current)

Boh-Ram Kim is an author at National Cancer Center specializing in cancer pharmacology, pharmacodynamics of anticancer agents, and oncology.

Publications per year

2013–2014

2

Publications

2

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts

Mi Sun Park, Seung Myung Dong, Boh-Ram Kim et al. · Oncotarget · 2014 · 70 citations · Full text

, , +17

BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents

Heon Jong Yoo, Boh-Ram Kim, Hyun‐Jung Byun et al. · The International Journal of Biochemistry & Cell Biology · 2013 · 11 citations

, , +8

1–2 of 2